Hepatitis

Real Water Tries to Sink the FDA’s Probe

Last month, we reported on an FDA safety warning that connected Real Water-brand alkaline water to outbreaks of hepatitis. Since then the story has taken crime-novel-like twists and turns including...

Two recalls, safety warning mean time to check the pantry

Two new recalls and a safety warning mean that it’s time to check your pantry to ensure that your family and pets are protected from health risks.

Hep C Cases Rise In Pregnant Women, And Here's Why

Science reveals 75 percent of people with Hepatitis C don't even know they're infected.

Kidney Transplants From Hep C Donors Now Possible

A recent study has shown that when kidneys from hepatitis C patients are transplanted into healthy recipients, the virus can be eradicated through a course of anti-viral medications.

4 Rare Diarrhea Causes

A little diarrhea will work itself out, but if you’ve got it bad, you might have one of these serious problems.

Can Drinking Too Many Energy Drinks Lead To Hepatitis?

A man develops acute hepatitis after drinking too many energy drinks.

The Cure For Hepatitis C May Come With Hidden Risks: FDA

The FDA is warning people infected with both Hepatitis B and C that a class of highly effective drugs for Hep C may inadvertently revive Hep B.

What You Need To Know About The Hepatitis A Outbreak

An outbreak of Hepatitis A associated with frozen strawberries has affected over 50 people in five states — what should you know?

How WHO Plans To Get Rid Of Hepatitis By 2030

The World Hepatitis Alliance is committed to #NOHep being a reality by 2030.

Hepatitis Kills As Many People As HIV, Malaria, And Tuberculosis

Despite medications that can prevent or cure the group of viral diseases that cause hepatitis, a new report finds that they collectively killed 1.45 million people in 2013.

India Patent Office Approves Gilead's Hepatitis C Drug Patent

India has reversed course and granted approval to Gilead Sciences Inc's patent for its hepatitis C drug Sovaldi, marking a setback for patient groups who said the move could stop affordable copies of the drug.